Glucagon administration system and methods
First Claim
Patent Images
1. A medicine administration system, comprising:
- a disposable and non-reusable pump device including;
a pump housing that defines a space to receive an insulin cartridge; and
a drive system to dispense insulin when the insulin cartridge is received by the pump housing, the drive system including a piston rod that is incrementally movable to apply a dispensing force;
a removable controller device including;
a controller housing that is removably attachable to the pump housing in a fixed relationship to provide an electrical connection between the controller device and the pump device;
control circuitry arranged in the controller housing to electrically communicate with the drive system in the pump housing;
a user interface connected to the control circuitry, the user interface including a display and one or more user-selectable buttons; and
a wireless communication device to receive glucose information from a wearable monitoring device, the glucose information being indicative of a blood glucose level of the user,wherein the removable controller device displays a suggested glucagon dosage in response to user input to the user interface, the suggested glucagon dosage being at least partially dependent upon a glucose sensitivity value stored by the controller device, a target blood glucose level stored by the controller device, and the blood glucose level of the user; and
a glucagon injector pen device that is separate from the pump device and the controller device, the glucagon injector device being configured to dispense glucagon in an amount equal to the suggested glucagon dosage that is displayed by the controller device.
6 Assignments
0 Petitions
Accused Products
Abstract
Some embodiments a glucagon administration system can provide a suggested glucagon dosage based on one or more particular parameters (e.g., the user'"'"'s recent blood glucose characteristics, a glucagon sensitivity value of the user, and other parameters). In some circumstances, the glucagon administration system can receive information indicative of the user'"'"'s blood glucose level and suggest a glucagon dosage that is at least partially dependent upon a previously stored glucagon sensitivity for the user.
-
Citations
11 Claims
-
1. A medicine administration system, comprising:
-
a disposable and non-reusable pump device including; a pump housing that defines a space to receive an insulin cartridge; and a drive system to dispense insulin when the insulin cartridge is received by the pump housing, the drive system including a piston rod that is incrementally movable to apply a dispensing force; a removable controller device including; a controller housing that is removably attachable to the pump housing in a fixed relationship to provide an electrical connection between the controller device and the pump device; control circuitry arranged in the controller housing to electrically communicate with the drive system in the pump housing; a user interface connected to the control circuitry, the user interface including a display and one or more user-selectable buttons; and a wireless communication device to receive glucose information from a wearable monitoring device, the glucose information being indicative of a blood glucose level of the user, wherein the removable controller device displays a suggested glucagon dosage in response to user input to the user interface, the suggested glucagon dosage being at least partially dependent upon a glucose sensitivity value stored by the controller device, a target blood glucose level stored by the controller device, and the blood glucose level of the user; and a glucagon injector pen device that is separate from the pump device and the controller device, the glucagon injector device being configured to dispense glucagon in an amount equal to the suggested glucagon dosage that is displayed by the controller device. - View Dependent Claims (2, 3)
-
-
4. A medicine administration system, comprising:
-
a pump device including; a pump housing that defines a space to receive an insulin cartridge; and a drive system to dispense insulin when the insulin cartridge is received by the pump housing; a controller device including; control circuitry configured to communicate with the drive system in the pump housing; and a wireless communication device to receive glucose information from a wearable monitoring device, the glucose information being indicative of a blood glucose level of the user, a user interface in communication with the control circuitry of the controller device, the user interface including a display and one or more user input components; wherein the user interface displays a suggested glucagon dosage, the suggested glucagon dosage being at least partially dependent upon a glucose sensitivity value stored by the controller device, a target blood glucose level stored by the controller device, and the blood glucose level of the user; and a glucagon injector pen device including; a housing that is physically separate from the pump housing; wherein the glucagon injector device is configured to dispense glucagon in an amount equal to the suggested glucagon dosage that is displayed by the user interface. - View Dependent Claims (5, 6, 7, 8, 9, 10)
-
-
11. A medicine administration system, comprising:
-
a pump device including; a pump housing that defines a space to receive an insulin cartridge; and a drive system to dispense insulin when the insulin cartridge is received by the pump housing; a controller device including; control circuitry configured to communicate with the drive system in the pump housing; and a wireless communication device to receive glucose information from a wearable monitoring device, the glucose information being indicative of a blood glucose level of the user, a user interface in communication with the control circuitry of the controller device, the user interface including a display and one or more user input components; wherein the user interface displays a suggested glucagon dosage; and a glucagon injector pen device that is separate from the pump device and the controller device, the glucagon injector pen device being configured to dispense glucagon in an amount equal to the suggested glucagon dosage that is displayed by the user interface.
-
Specification